Filarial nematode secreted product ES-62 is an anti-inflammatory agent: Therapeutic potential of small molecule derivatives and ES-62 peptide mimetics

被引:43
|
作者
Harnett, W
Harnett, MM
机构
[1] Univ Strathclyde, Dept Immunol, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland
基金
英国惠康基金;
关键词
ES-62; filarial nematodes; inflammation; signal transduction;
D O I
10.1111/j.1440-1681.2006.04400.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The 'hygiene hypothesis' postulates that the recent increased incidence of allergic or autoimmune diseases (e.g. asthma, type I diabetes) in the West reflects an absence of appropriate priming of the immune response by infectious agents, such as parasitic worms, during childhood. 2. Consistent with this, it has long been recognized that several autoimmune disorders, such as rheumatoid arthritis (RA), a T helper (Th) 1-mediated autoimmune disease characterized by excess production of pro-inflammatory cytokines, such as tumour necrosis factor-a, exhibit reduced incidence and severity in geographical regions with high parasite load, suggesting that environmental factors may subtly alter disease progression. 3. Infection with worms also appears to suppress Th2-biased inflammatory disorders, such as asthma, because there also appears to be an inverse correlation between parasite load and atopy. This is perhaps more surprising, given that helminths often induce strong Th2-type immune responses characterized by release of specific cytokines, such as interleukin (IL)-4, IL-5 and IL-13. 4. Therefore, these findings suggest that the co-evolution of helminths with hosts, which has resulted in the ability of worms to modulate inflammatory responses in order to promote parasite survival, may also have generated a predisposition for the host to develop autoimmunity and allergy in the absence of infection. 5. The mechanisms underlying such immunomodulation are not clear, but appear to involve the release of parasite-derived molecules that allow the worms to modulate or evade the host immune response by a number of mechanisms, including skewing of cytokine responses and the induction of T regulatory cells. 6. In the present review we discuss the properties of one such filarial nematode-derived immunomodulatory molecule, namely ES-62, its anti-inflammatory action and the therapeutic potential of small molecule derivatives and peptides that mimic its action.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 50 条
  • [1] The anti-inflammatory potential of the filarial nematode secreted product, ES-62
    Harnett, W
    Harnett, MM
    Leung, BP
    Gracie, JA
    McInnes, LB
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (05) : 553 - 559
  • [2] Immunomodulatory Activity and Therapeutic Potential of the Filarial Nematode Secreted Product, ES-62
    Harnett, William
    Harnett, Margaret M.
    PATHOGEN-DERIVED IMMUNOMODULATORY MOLECULES, 2009, 666 : 88 - 94
  • [3] A potential therapeutic role for the filarial nematode secreted product, ES-62 in Asthma
    Kean, Dorothy E.
    Melendez, Alirio J.
    McSharry, Charles
    Harnett, Margaret M.
    Harnett, William
    INFLAMMATION RESEARCH, 2005, 54 : S136 - S136
  • [4] ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode Acanthocheilonema viteae
    Pineda, Miguel A.
    Lumb, Felicity
    Harnett, Margaret M.
    Harnett, William
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2014, 194 (1-2) : 1 - 8
  • [5] Immunomodulatory properties of the filarial nematode secreted product, ES-62
    Harnett, W.
    Houston, K. M.
    Gracie, J. A.
    Leung, B.
    McInnes, I. B.
    Harnett, M. M.
    ICOPA XI: PROCEEDINGS OF THE 11TH INTERNATIONAL CONGRESS OF PARASITOLOGY, 2006, : 97 - +
  • [6] ES-62, a filarial nematode-derived immunomodulator with anti-inflammatory potential
    Harnett, W
    McInnes, IB
    Harnett, MM
    IMMUNOLOGY LETTERS, 2004, 94 (1-2) : 27 - 33
  • [7] The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease
    Harnett, M. M.
    Melendez, A. J.
    Harnett, W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 159 (03): : 256 - 267
  • [8] Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62
    Goodridge, HS
    Stepek, G
    Harnett, W
    Harnett, MM
    IMMUNOLOGY, 2005, 115 (03) : 296 - 304
  • [9] The pathology of Plasmodium chabaudi infection is not ameliorated by the secreted filarial nematode immunomodulatory molecule, ES-62
    Lamb, T. J.
    Voisine, C.
    Koernig, S.
    Egan, C. A.
    Harnett, W.
    Langhorne, J.
    PARASITE IMMUNOLOGY, 2007, 29 (05) : 271 - 276
  • [10] Subversion of immune cell signal transduction pathways by the secreted filarial nematode product, ES-62
    Harnett, W
    Goodridge, HS
    Harnett, MM
    PARASITOLOGY, 2005, 130 : S63 - S68